Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J cancer 197, 33(7), 1141-1148 [2] (multiple letters)

P. Limonta, G. Pratesi, R. M. Moretti, M. M. Marelli, M. Motta, D. Dondi, Andrew V Schally, A. Jungwirth, A. M. Comaru-Schally

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)1134-1136
Number of pages3
JournalEuropean Journal of Cancer
Volume34
Issue number7
DOIs
StatePublished - Jul 15 1998
Externally publishedYes

Fingerprint

Hormone Antagonists
Bombesin
Peptide Fragments
Gonadotropin-Releasing Hormone
Androgens
Prostatic Neoplasms
Growth
Neoplasms
cetrorelix
Hca(6)-Leu(13)-psi(CH2N)-Tac(14)-bombesin(6-14)

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J cancer 197, 33(7), 1141-1148 [2] (multiple letters). / Limonta, P.; Pratesi, G.; Moretti, R. M.; Marelli, M. M.; Motta, M.; Dondi, D.; Schally, Andrew V; Jungwirth, A.; Comaru-Schally, A. M.

In: European Journal of Cancer, Vol. 34, No. 7, 15.07.1998, p. 1134-1136.

Research output: Contribution to journalArticle

@article{1626e1ae6e7e42c1a5a7557d14d3347e,
title = "Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J cancer 197, 33(7), 1141-1148 [2] (multiple letters)",
author = "P. Limonta and G. Pratesi and Moretti, {R. M.} and Marelli, {M. M.} and M. Motta and D. Dondi and Schally, {Andrew V} and A. Jungwirth and Comaru-Schally, {A. M.}",
year = "1998",
month = "7",
day = "15",
doi = "10.1016/S0959-8049(97)10143-5",
language = "English",
volume = "34",
pages = "1134--1136",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Comments on inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J cancer 197, 33(7), 1141-1148 [2] (multiple letters)

AU - Limonta, P.

AU - Pratesi, G.

AU - Moretti, R. M.

AU - Marelli, M. M.

AU - Motta, M.

AU - Dondi, D.

AU - Schally, Andrew V

AU - Jungwirth, A.

AU - Comaru-Schally, A. M.

PY - 1998/7/15

Y1 - 1998/7/15

UR - http://www.scopus.com/inward/record.url?scp=0031831019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031831019&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(97)10143-5

DO - 10.1016/S0959-8049(97)10143-5

M3 - Article

C2 - 9849469

AN - SCOPUS:0031831019

VL - 34

SP - 1134

EP - 1136

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 7

ER -